title: Effect of cabergoline on increase of several ER stress-related molecules in 6-OHDA-lesioned mice.
authors.forename: Ken-Ichi
authors.initials: K
authors.lastname: Tanaka
authors.forename: Saki
authors.initials: S
authors.lastname: Fukuoka
authors.forename: Saki
authors.initials: S
authors.lastname: Kawahara
authors.forename: Naotaka
authors.initials: N
authors.lastname: Kimoto
authors.forename: Norio
authors.initials: N
authors.lastname: Ogawa
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D000077465:Cabergoline; D053454:Caspase 12 / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000187:drug effects* / Q000378:metabolism; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects*; D004873:Ergolines / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009842:Oligopeptides / Q000378:metabolism; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism; D051742:Transcription Factor CHOP / Q000378:metabolism
chemical_list: D000978:Antiparkinson Agents; C539791:Bax-inhibiting peptide, BIP; D004873:Ergolines; D009842:Oligopeptides; D051742:Transcription Factor CHOP; D016627:Oxidopamine; D053454:Caspase 12; D000077465:Cabergoline